Clinical Trials Directory

Trials / Completed

CompletedNCT01338909

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)and Presenting With High Platelet Reactivity, as Assessed With a Point of Care Assay, After 600mg Clopidogrel Loading Dose

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
University of Patras · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This is a single-center, randomized, single-blind, investigator-initiated, pharmacological study with a parallel design. Patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention and presenting high platelet reactivity as assessed with the Verify Now P2Y12 assay-Accumetrics(Platelet Reactivity Units -PRU≥235) at 2 hours post-clopidogrel 600mg LD (Day 0), as assessed with the Verify Now P2Y12 assay, will be randomized after informed consent, in a 1:1 ratio to the following treatment groups: Group Α: Clopidogrel 150mg per day,starting from Day 1 until Day 5 (5 days after randomization) Group Β: Prasugrel 60 mg immediate loading (on Day 0) followed by 10mg/day starting from Day 1 until Day 5 (5 days after randomization). Platelet reactivity assessment will be performed 2 hours after randomization (Day 0), 24 h after randomization (Day 1) and on Day 5. Documentation of major adverse cardiac events (death, myocardial infarction, stroke, revascularization procedure with PCI or CABG)and serious adverse events (bleeding, other adverse events)will be performed until Day 5.

Conditions

Interventions

TypeNameDescription
DRUGPrasugrelPrasugrel 60mg immediate loading dose (Day 0)followed by 10mg/day starting from Day 1 until Day 5
DRUGClopidogrelClopidogrel 150mg/d starting from Day 1

Timeline

Start date
2011-04-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2011-04-20
Last updated
2011-09-30

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01338909. Inclusion in this directory is not an endorsement.

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial In (NCT01338909) · Clinical Trials Directory